You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allergic rhinitis

Showing 26 - 50 of 5,291
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Rhinitis Trial (MAZ-101association, DYMISTA®)

Not yet recruiting
  • Allergic Rhinitis
  • (no location specified)
Jan 12, 2023

Evaluation Using Microneedle Patch in Allergic Rhinitis

Recruiting
  • Rhinitis, Allergic
  • Evaluation of clinical indicators, Sample collection before& after immunotherapy
  • Sample collection before& after immunotherapy
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 28, 2023

Allergic Rhinitis Trial in Toronto (AllerPops)

Completed
  • Allergic Rhinitis
  • AllerPops
  • Toronto, Ontario, Canada
    Dicentra
Jul 20, 2023

Allergic Rhinitis, Cough Trial (Bepotastine, Placebo)

Completed
  • Allergic Rhinitis
  • Cough
  • Seoul, Korea, Republic of
    Asan medical center
Jan 3, 2023

Allergy to Cats Trial (Zafirlukast)

Not yet recruiting
  • Allergy to Cats
  • (no location specified)
Sep 29, 2023

Rhinitis, Allergic Trial in Zunyi (EGR2)

Enrolling by invitation
  • Rhinitis, Allergic
  • EGR2
  • Zunyi, China
    Department of Central Laboratory of the Third Affiliated Hospita
Feb 9, 2023

Allergic Rhinitis Trial in Kuala Lumpur (Rhinophototherapy, Nasonex Nasal Spray)

Not yet recruiting
  • Allergic Rhinitis
  • Rhinophototherapy
  • Nasonex Nasal Spray
  • Kuala Lumpur, Cheras, Malaysia
    Otorhinolaryngology Department, Head and Neck Surgery, Faculty o
Jun 25, 2023

Allergic Rhinitis Trial in Den Haag (Acupuncture, Antihistamine nasal spray)

Not yet recruiting
  • Allergic Rhinitis
  • Acupuncture
  • Antihistamine nasal spray
  • Den Haag, Zuid-Holland, Netherlands
    Mermaid Medicine®
Feb 1, 2023

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo

Recruiting
  • Seasonal Allergic Rhinitis
  • Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
  • +2 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Nov 6, 2023

Seasonal Allergic Rhinitis Trial in Kingston (Fexofenadine, Placebo)

Recruiting
  • Seasonal Allergic Rhinitis
  • Kingston, Ontario, Canada
    Investigational Site Number :1240001
Jan 29, 2023

Concomitant Intranasal Antihistamine and Corticosteroid in

Recruiting
  • Allergic Rhinitis
  • concomitant intranasal antihistamine and corticosteroid
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Jan 23, 2023

Beetween Allergic Rhinitis and Seasonal EOE Exacerbations

Recruiting
  • Eosinophilic Esophagitis
  • Respiratory Allergy
    • Roma, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 2, 2023

    COVID-19, Allergic Rhinitis Trial in Chengdu (no intervention)

    Active, not recruiting
    • COVID-19
    • Allergic Rhinitis
    • no intervention
    • Chengdu, China
      Hospital of Chengdu University of Traditional Chinese Medicine
    Mar 2, 2023

    Monitoring Allergen Immunotherapy in Allergic Rhinitis

    Recruiting
    • Immunotherapy
    • +2 more
    • A nasal fluid Basophil Activation Test (BAT)
    • Arnhem, Netherlands
      Rijnstate Hospital
    Nov 10, 2022

    Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen, Healthy Volunteers Trial in Tustin, Mississauga (B244 suspension,

    Completed
    Has Results
    • Allergic Rhinitis
    • +2 more
    • B244 suspension
    • Vehicle
    • Tustin, California
    • +1 more
    Oct 31, 2022

    Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

    Recruiting
    • Seasonal Allergic Rhinitis
    • LP-003 dose 1
    • +2 more
    • Beijing, Beijing, China
    • +16 more
    Sep 18, 2023

    Allergic Rhinitis Trial in Yerevan (Seawater nasal spray)

    Recruiting
    • Allergic Rhinitis
    • Seawater nasal spray
    • Yerevan, Armenia
      "Heratsi" Hospital Complex No.1
    Aug 16, 2022

    Allergic Rhinitis Trial in São Paulo (Administration of investigation of Eurofarma drug, Administration of Comparator)

    Not yet recruiting
    • Allergic Rhinitis
    • Administration of investigation of Eurofarma drug
    • Administration of Comparator
    • São Paulo, Brazil
      Eurofarma Laboratorios S.A
    Dec 12, 2022

    Allergic Rhinitis Trial in Changsha (TQC3564 tablets, Placebo tablets, TQC3564 tablets, montelukast sodium tablets)

    Recruiting
    • Allergic Rhinitis
    • TQC3564 tablets
    • +3 more
    • Changsha, Hunan, China
      Xiangya Hospital Central South University
    Nov 1, 2022

    Seasonal Allergic Rhinitis Trial (Azelastine + Mometazone, nasal spray, Momat Rhino Advance)

    Not yet recruiting
    • Seasonal Allergic Rhinitis
    • Azelastine + Mometazone, nasal spray
    • Momat Rhino Advance
    • (no location specified)
    Dec 16, 2022

    Allergic Rhinitis Trial in Giza (pranayama plus acupoint stimulation by laser, acupoint stimulation by laser)

    Recruiting
    • Allergic Rhinitis
    • pranayama plus acupoint stimulation by laser
    • acupoint stimulation by laser
    • Giza, Egypt
      Cairo Unoversity
    Sep 21, 2022

    Pediatric Patients With Allergic Rhinitis and/or Asthma

    Completed
    • Allergic Rhinitis
    • +3 more
    • Oral examination
    • Pavia, Lombardy, Italy
      Unit of Orthodontics and Pediatric Dentistry - Section of Dentis
    Oct 7, 2022

    Allergic Rhinitis Due to Grass Pollen Trial in Strasbourg (Grass Pollen Allergen Exposure)

    Completed
    • Allergic Rhinitis Due to Grass Pollen
    • Grass Pollen Allergen Exposure
    • Strasbourg, France
      ALYATEC
    Oct 27, 2023

    Rhinitis Allergic Trial (Fexofenadine HCL and pseudoephedrine HCL)

    Not yet recruiting
    • Rhinitis Allergic
    • Fexofenadine HCL and pseudoephedrine HCL
    • (no location specified)
    Jan 31, 2023

    Effects of Immunotherapy Trial in Zagazig (Sublingual immunotherapy)

    Completed
    • Effects of Immunotherapy
    • Sublingual immunotherapy
    • Zagazig, Egypt
      Fatma Zohry Kamel Khater
    Dec 18, 2022